Mazen M. Dimachkie (2022) “Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond”, RRNMF Neuromuscular Journal, 3(2), pp. 13–26. doi:10.17161/rrnmf.v3i2.16304.